Two-Agent Combo Trumps Monotherapy in Early RA

Higher Prevalence of Sarcopenia Reported in Patients with Rheumatoid Arthritis

Multibiomarker Disease Activity Scores Support Assessment of Biosimilarity in RA

Pirfenidone Slows Decline of Forced Vital Capacity in RA-Associated Interstitial Lung Disease